GADD45G anticorps (AA 96-109)
Aperçu rapide pour GADD45G anticorps (AA 96-109) (ABIN1886724)
Antigène
Voir toutes GADD45G AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 96-109
-
Purification
- Purified by antigen-affinity chromatography.
-
Immunogène
- Synthetic peptide contain a sequence corresponding to a region within amino acids 96 and 109 (O95257) of GADD45G
-
-
-
-
Indications d'application
-
Suggested dilutions:
Western blotting: 1.500-1.3000
Immunofluorescence: 1.100-1.200 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- 0.1 M Tris-buffered saline with 10 % Glycerol (pH 7.0).0.01 % Thimerosal was added as a preservative.
-
Agent conservateur
- Thimerosal (Merthiolate)
-
Précaution d'utilisation
- Biohazard Informations: This product contains thimerosal which is hazardous.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at -20 °C for long term preservation (recommended). Store at 4 °C for short term use.
-
-
- GADD45G (Growth Arrest and DNA-Damage-Inducible, gamma (GADD45G))
-
Autre désignation
- GADD 45 gamma
-
Sujet
-
This gene is a member of a group of genes whose transcript levels are increased following stressful growth arrest conditions and treatment with DNA-damaging agents.The protein encoded by this gene responds to environmental stresses by mediating activation of the p38/JNK pathway via MTK1/MEKK4 kinase.The GADD45G is highly expressed in placenta.[provided by RefSeq]
Synonyms: CR6, DDIT2, GRP17, GADD45gamma -
Poids moléculaire
- 17 kDa
-
ID gène
- 10912
-
NCBI Accession
- NP_006696, NM_006705
-
Pathways
- Cycle Cellulaire
Antigène
-